直接作用型経口抗凝固薬(DOAC)による静脈血栓塞栓症の治療
Saved in:
| Published in | Shinzo Vol. 52; no. 2; pp. 103 - 108 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Japanese |
| Published |
公益財団法人 日本心臓財団
15.02.2020
Japan Heart Foundation |
| Online Access | Get full text |
| ISSN | 0586-4488 2186-3016 |
| DOI | 10.11281/shinzo.52.103 |
Cover
| Author | 中村, 真潮 |
|---|---|
| Author_xml | – sequence: 1 fullname: 中村, 真潮 organization: 陽だまりの丘なかむら内科 |
| BackLink | https://cir.nii.ac.jp/crid/1390850722285770368$$DView record in CiNii |
| BookMark | eNo9kDtLw1AAhS-iYK1d_QUOOqTeR25ys1nqE4pddA735mFTaipJF51sEVqs6KBYSm2xiCAoDqKL4q-JSeq_MKXi8p0D53CGMwem3aprAbCAYBYhzNCKX3Lc42qW4iyCZAqkMGKKRCBSpkEK0sTLMmOzIOP7joAQMhVpGkmBnbj3Fl08fH_dxteP4aAdv5-Hl_fRWSds9sPex-jmeWmtmMsvB_WnoNEKGu2ffnd02hoNT6K7q3A4SBh3mkH9JXr9jLuNeTBj84pvZf40DfY21nfzW1KhuLmdzxWkMiaESbbgxLRlFZuCcGobBreZyhlksiBChiYXkFmqISNZ0RCjJjEFUojNKEJCKEwjabA42XUdRzecMRHRIKNQxRgzqqqQKCyprU5qZb_G9y390HMOuHekc6_mGBVLn5ymU6zjMZLn_iOjxD29zMkvg0qAYg |
| ContentType | Journal Article |
| Copyright | 2020 公益財団法人 日本心臓財団 |
| Copyright_xml | – notice: 2020 公益財団法人 日本心臓財団 |
| DBID | RYH |
| DOI | 10.11281/shinzo.52.103 |
| DatabaseName | CiNii Complete |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2186-3016 |
| EndPage | 108 |
| ExternalDocumentID | 130008028557 article_shinzo_52_2_52_103_article_char_ja |
| GroupedDBID | ALMA_UNASSIGNED_HOLDINGS JSF KQ8 MOJWN RJT RYH |
| ID | FETCH-LOGICAL-j2338-fba3df472db3a5fccaf87a8084b3b40dab08e7c41469185d3db163f8511bb6893 |
| ISSN | 0586-4488 |
| IngestDate | Thu Jun 26 22:30:54 EDT 2025 Wed Sep 03 06:31:11 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 2 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j2338-fba3df472db3a5fccaf87a8084b3b40dab08e7c41469185d3db163f8511bb6893 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/shinzo/52/2/52_103/_article/-char/ja |
| PageCount | 6 |
| ParticipantIDs | nii_cinii_1390850722285770368 jstage_primary_article_shinzo_52_2_52_103_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 2020/02/15 2020-02-15 |
| PublicationDateYYYYMMDD | 2020-02-15 |
| PublicationDate_xml | – month: 02 year: 2020 text: 2020/02/15 day: 15 |
| PublicationDecade | 2020 |
| PublicationTitle | Shinzo |
| PublicationTitleAlternate | 心臓 |
| PublicationTitle_FL | 心臓 Shinzo |
| PublicationYear | 2020 |
| Publisher | 公益財団法人 日本心臓財団 Japan Heart Foundation |
| Publisher_xml | – name: 公益財団法人 日本心臓財団 – name: Japan Heart Foundation |
| References | 3) Breddin HK, Hach-Wunderle V, Nakov R, et al：Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med 2001；344：626-631 2) Nakamura M, Okano Y, Minamiguchi H, et al：Multidetector-row computed tomography-based clinical assessment of fondaparinux for treatment of acute pulmonary embolism and acute deep vein thrombosis in Japanese patients. Circ J 2011；75：1424-1432 9) Agnelli G, Buller HR, Cohen A, et al：Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013；369：799-808 10) Yamada N, Hirayama A, Maeda H, et al：Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program. Thromb J 2015；13：2 6) Hokusai-VTE Investigators, Büller HR, Décousus H, Grosso MA, et al：Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 2013；369：1406-1415 5) Nakamura M, Wang YQ, Wang C, et al：Efficacy and safety of edoxaban for treatment of venous thromboembolism：a subanalysis of East Asian patients in the Hokusai-VTE trial. J Thromb Haemost 2015；13：1606-1614 12) Agnelli G, Buller HR, Cohen A, et al：Apixaban for extended treatment of venous thromboembolism. N Engl J Med 2013；368：699-708 13) Prandoni P, Noventa F, Ghirarduzzi A, et al：The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1, 626 patients. Haematologica 2007；92：199-205 15) Raskob GE, van Es N, Verhamme P, et al；Hokusai VTE Cancer Investigators：Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism. N Engl J Med 2018；378：615-624 16) Nakamura M, Yamada N, Asamura T, et al：Safety and Effectiveness of Edoxaban in Japanese Patients With Venous Thromboembolism - An Interim Analysis of Data From a Japanese Postmarketing Observational Study(ETNA-VTE-Japan). Circ J 2019；83：1394-1404 7) EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, et al：Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010；363：2499-2510 8) EINSTEIN-PE Investigators, Büller HR, Prins MH, Lensin AW, et al：Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012；366：1287-1297 1) Nakamura M, Yamada N, Ito M：Current management of venous thromboembolism in Japan：Current epidemiology and advances in anticoagulant therapy. J Cardiol 2015；66：451-459 4) Nakamura M, Miyata T, Ozeki Y, et al：Current venous thromboembolism management and outcomes in Japan. Circ J 2014；78：708-717 11) Nakamura M, Nishikawa M, Komuro I, et al：Apixaban for the Treatment of Japanese Subjects with Acute Venous Thromboembolism(AMPLIFY-J Study). Circ J 2015；79：1230-1236 14) Lee AY, Rickles FR, Julian JA, et al：Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol 2005；23：2123-2129 |
| References_xml | – reference: 11) Nakamura M, Nishikawa M, Komuro I, et al：Apixaban for the Treatment of Japanese Subjects with Acute Venous Thromboembolism(AMPLIFY-J Study). Circ J 2015；79：1230-1236 – reference: 14) Lee AY, Rickles FR, Julian JA, et al：Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol 2005；23：2123-2129 – reference: 10) Yamada N, Hirayama A, Maeda H, et al：Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program. Thromb J 2015；13：2 – reference: 3) Breddin HK, Hach-Wunderle V, Nakov R, et al：Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med 2001；344：626-631 – reference: 8) EINSTEIN-PE Investigators, Büller HR, Prins MH, Lensin AW, et al：Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012；366：1287-1297 – reference: 2) Nakamura M, Okano Y, Minamiguchi H, et al：Multidetector-row computed tomography-based clinical assessment of fondaparinux for treatment of acute pulmonary embolism and acute deep vein thrombosis in Japanese patients. Circ J 2011；75：1424-1432 – reference: 4) Nakamura M, Miyata T, Ozeki Y, et al：Current venous thromboembolism management and outcomes in Japan. Circ J 2014；78：708-717 – reference: 15) Raskob GE, van Es N, Verhamme P, et al；Hokusai VTE Cancer Investigators：Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism. N Engl J Med 2018；378：615-624 – reference: 6) Hokusai-VTE Investigators, Büller HR, Décousus H, Grosso MA, et al：Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 2013；369：1406-1415 – reference: 9) Agnelli G, Buller HR, Cohen A, et al：Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013；369：799-808 – reference: 13) Prandoni P, Noventa F, Ghirarduzzi A, et al：The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1, 626 patients. Haematologica 2007；92：199-205 – reference: 1) Nakamura M, Yamada N, Ito M：Current management of venous thromboembolism in Japan：Current epidemiology and advances in anticoagulant therapy. J Cardiol 2015；66：451-459 – reference: 5) Nakamura M, Wang YQ, Wang C, et al：Efficacy and safety of edoxaban for treatment of venous thromboembolism：a subanalysis of East Asian patients in the Hokusai-VTE trial. J Thromb Haemost 2015；13：1606-1614 – reference: 7) EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, et al：Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010；363：2499-2510 – reference: 12) Agnelli G, Buller HR, Cohen A, et al：Apixaban for extended treatment of venous thromboembolism. N Engl J Med 2013；368：699-708 – reference: 16) Nakamura M, Yamada N, Asamura T, et al：Safety and Effectiveness of Edoxaban in Japanese Patients With Venous Thromboembolism - An Interim Analysis of Data From a Japanese Postmarketing Observational Study(ETNA-VTE-Japan). Circ J 2019；83：1394-1404 |
| SSID | ssib000871993 ssib005879815 ssib058494393 ssj0000605722 ssib002822027 |
| Score | 2.2152538 |
| SourceID | nii jstage |
| SourceType | Publisher |
| StartPage | 103 |
| Title | 直接作用型経口抗凝固薬(DOAC)による静脈血栓塞栓症の治療 |
| URI | https://www.jstage.jst.go.jp/article/shinzo/52/2/52_103/_article/-char/ja https://cir.nii.ac.jp/crid/1390850722285770368 |
| Volume | 52 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 心臓, 2020/02/15, Vol.52(2), pp.103-108 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2186-3016 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000605722 issn: 0586-4488 databaseCode: KQ8 dateStart: 19690101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LaxRBEB6SePEiiopRIzlYoMjE2Xl2H2d2ZwkqASGB3IZ57ED2kARJLjmZICQY0YNiCDHBIIKgeBC9KP6adXfjv_Crnt3NhOQQFZbeprq7qqaqp6uq6anWtJuNFMtibEu9AYOAACWPdWHZqe7mmcz4nnIjUactptzJGfverDM7NPygdGppeSmZSFdO_K7kX7QKGPTKX8n-hWYHSAFAHfpFCQ2jPJWOKfRIBhTYFLokQvIdCm0KaiSrqskmX1DokAxJBAwJHBJVhog6-ZYa5ZP0FAT9a6ozEPoUCpIu-VU4oAgf8ScptOB2kh-oiklC9CuASB4sJQ8TtmoS5Ff4GAVo-AZJi1EDAlYOIR7TBuEeZtUUmBQoXoGtuDCo7zszhqBOwlJU0GGwZKmnBsEaI2BGKjxzFJIqybpCWwP-8hYH4lm-cMUZTEolBIcfuZCqUEIAO-C6EEshscAiWcjZx--OIukp0btMzq8e5_M4otL66whXR_RamIeGgvENXjrWRLdsQByz9KKYJWtQMaySY1FRCSxOsFmmYKPFO44rCxOOOTEYdiQPeG-WRUW_yDEjkwt0jvpN_KFe1ES0cMaEjeOLTO4_LDvbHp_WLAfbvPN1uBoLT5Yy98AzlfBWrcGOpYHIt5dZtC-ZXhZUfoK7R_iHP9dEdMNpK4bn5-ZKLtv0ee1cL9Ya9wu-L2hDzfiiNtXd-dp5_v7XzzfdVx_ae5vdb8_aL951nm6113fbO98PXn-6xRP-dmv1Y2tto7W2-Xt3--DJxsH-487bl-39PZTdrfXW6ufOlx_d7bVL2kw9nK5O6r1LRfSmacG450lsZbntmVlixU6OBSwXXiwMYSdWYhtZnBii4aU2PAgJXzazsgQhS86BSZK48O4vayPzC_ONK9q4mUNKGG_Bz7VzO00asZMiPEpNL3Ndwx3VZCGEaLHIHBOdXoej2hjkFqVzXCJK48ySHu_WOh6nzBNX_wP3Ne3s4Vt2XRtZerTcGINrvZTcUDPmD4vXrMs |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E7%9B%B4%E6%8E%A5%E4%BD%9C%E7%94%A8%E5%9E%8B%E7%B5%8C%E5%8F%A3%E6%8A%97%E5%87%9D%E5%9B%BA%E8%96%AC%28DOAC%29%E3%81%AB%E3%82%88%E3%82%8B%E9%9D%99%E8%84%88%E8%A1%80%E6%A0%93%E5%A1%9E%E6%A0%93%E7%97%87%E3%81%AE%E6%B2%BB%E7%99%82&rft.jtitle=%E5%BF%83%E8%87%93&rft.au=%E4%B8%AD%E6%9D%91%2C+%E7%9C%9F%E6%BD%AE&rft.date=2020-02-15&rft.pub=%E5%85%AC%E7%9B%8A%E8%B2%A1%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%BF%83%E8%87%93%E8%B2%A1%E5%9B%A3&rft.issn=0586-4488&rft.eissn=2186-3016&rft.volume=52&rft.issue=2&rft.spage=103&rft.epage=108&rft_id=info:doi/10.11281%2Fshinzo.52.103&rft.externalDocID=article_shinzo_52_2_52_103_article_char_ja |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0586-4488&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0586-4488&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0586-4488&client=summon |